SCHEMBL20866200

SCHEMBL20866200

C#Cc1cccc(Nc2ncnc3cc(OC)c(OCc4ccccc4)cc23)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 18/20 0.82
▸ GAK O14976 3/20 0.82
▸ FBP1 P09467 2/20 0.82
▸ ALDH1A1 P00352 1/20 0.82
▸ MAPT P10636 1/20 0.82
▸ ERBB2 P04626 6/20 0.72
▸ RET P07949 3/20 0.72
▸ KDR P35968 3/20 0.72
▸ LCK P06239 3/20 0.72
▸ ABCG2 Q9UNQ0 2/20 0.72
▸ RIPK2 O43353 2/20 0.72
▸ BUB1 O43683 2/20 0.72
▸ STK10 O94804 2/20 0.72
▸ ABL1 P00519 2/20 0.72
▸ LYN P07948 2/20 0.72
▸ SRC P12931 2/20 0.72
▸ FGFR2 P21802 2/20 0.72
▸ FECH P22830 2/20 0.72
▸ FLT3 P36888 2/20 0.72
▸ MAP3K1 Q13233 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL667895 0.91 EGFR (1.00) EGFRGAKFBP1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL1507455 0.90 EGFR (0.98) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL30891782 0.88 EGFR (0.83) EGFRGAKERBB2RETKDR
SCHEMBL24535454 0.87 EGFR (0.94) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL2129452 0.87 EGFR (0.94) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL14964731 0.86 EGFR (0.82) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL28522667 0.86 EGFR (0.82) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL28523359 0.86 EGFR (0.82) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL1731532 0.86 EGFR (0.87) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL8870651 0.86 EGFR (0.81) EGFRGAKFBP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10251886-B1 4-anilinoquinazoline derivative and albumin conjugates thereof NATIONAL CHIAO TUNG UNIVERSITY (TW) 2019-04-09 — — US disclosed
US-10251886-B1 4-anilinoquinazoline derivative and albumin conjugates thereof NATIONAL CHIAO TUNG UNIVERSITY (TW) 2019-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10251886-B1 4-anilinoquinazoline derivative and albumin conjugates thereof KRAS, NRAS, ALB EGFR 4/4885GAK 355/4885FBP1 3562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback